This text is a result of machine translation.
AstraZeneca in China: Opportunities and Challenges [1/2]
AstraZeneca is a British pharmaceutical company founded in 1999 that focuses on discovering, developing, and commercializing prescription medicines in oncology, rare diseases, and biological medicals for cardiovascular, renal, metabolism, respiratory and immunology diseases.
Jul 05, 2022 03:21 PM
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
AI-driven Pharmaceutical Company Phil Rivers Nets Hundreds of Mns of CNY in Series A Round
Phil Rivers, incubated by the Institute of Computing Technology of the Chinese Academy of Sciences, is a platform company that drives drug discovery with 'computational medicine'.
Yesterday 10:08 PM
The battery plant jointly built by SK innovation and Ford was started in December last year
Precision Autoimmune Therapeutics Earned CNY 140 Mn in Angel Financing Round
Biotech firm Precision Autoimmune Therapeutics, specializing in the research and development of innovative drugs for autoimmune diseases, will focus on the precise therapies of autoimmune diseases.
Jul 06, 2022 09:53 PM
Anti-cancer Drugs Developer Affinity Completed Series A+ Round
Affinity, a biopharmaceutical company focusing on developing anti-cancer drugs, gained capital favor for its tumor microenvironment activated platform and opportunities it may bring to oncology treatment.
Jul 06, 2022 08:42 PM
30 Chinese Low-Carbon Tech Companies You May Want to Get to Know「2/2」
Jul 06, 2022 02:24 PM
30 Chinese Low-Carbon Tech Companies You May Want to Get to Know「1/2」
Jul 06, 2022 12:06 PM